European Patient Survey in Atrial Fibrillation (EUPS-AF), conducted prior to the approval and widespread uptake of direct thrombin and factor Xa inhibitors, found high patients’ satisfaction with their care: 85.5% of patients rated the quality of care on a five-point Likert scale as good, very good, or excellent [49]. This evidence concerns the gene F10 and atrial fibrillation.